Laser monotherapy in plantar fasciitis
DOI:
https://doi.org/10.25759/spmfr.92Abstract
Introduction: Plantar Fasciitis (PF) represents the most common cause of plantar heel pain. An initial conservative trial is recommended.
Objectives: To characterize demographic and symptomatic factors, previous therapy, results with laser monotherapy.
Material and Methods: Observational retrospective study (12 months period). The treatment consisted of infrared laser (AsGa 904nm; energy density 20J/cm2; peak potency 200mW). Descriptive and comparative statistical analysis was made (level of significance 0,05).
Results: Thirty-two patients with PF were followed-up, mean age 54,28 years (24-86; SD 13,95), 66% female, mean body mass index 30,18Kg/m2 (17,91-41,13; SD 5,19), 75% unilateral, mean time of symptoms onset 6,28 months (0,2-24; SD 6,82), 21 with previous pharmacotherapy and 12 with other PRM treatment modalities. Mean initial pain level (Numeric pain scale) was 7,31 (5-10; SD 1,38). Of the 26 patients treated (6 follow-up losses), 24 (92,3%) reported improvement. The average number of sessions was 28,5 (11-60; SD 14,01). The mean end pain level was 0,75 (0-5; SD 2,37), with an average pain level reduction of 89,7% (28,6%-100%; SD 0,16). The level of pain intensity at onset was superior in patients with higher body mass index (p=0,002). There were not found other statistical significant relations.
Conclusions: PF was characterized by a significant pain level (moderate to severe). Obesity was a risk factor for the initial pain intensity. Rate reduction in pain level intensity was very satisfactory. Infrared Low level laser therapy is a good therapeutic option, justifying the need for further evaluation through randomized controlled prospective studies.
Keywords: Laser Therapy; Fasciitis, Plantar; Pain; Physical Therapy Modalities.
Downloads
Downloads
How to Cite
Issue
Section
License
Copyright statement
Authors must also submit a copyright statement (as seen below) on article submission.
To the Editor-in-chief of the SPMFR Journal:
The below signed author(s) hereby state that the article
________________________________________ (ref. MFR_________) is
an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.
By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.
Signed by all authors
Date:
Names (capital letters):
Signatures:
The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.